Phospholipase C-δ1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 2, 2008, Pages

  Clarke, Christopher J ^a,b   Forman, Simon ^a   Pritchett, James ^a   Ohanian, Vasken ^a   Ohanian, Jacqueline ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Caveolae; Lipid rafts; Phosphoinositide; Signal transduction; Vascular smooth muscle

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM; ENDOTHELIN 1; INOSITOL PHOSPHATE; NORADRENALIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C DELTA1; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPID; PROTEIN KINASE C; U 73342; UNCLASSIFIED DRUG; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 PYRROLIDONE DERIVATIVE; ESTRANE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE C DELTA; PLCD1 PROTEIN, HUMAN; PLCD1 PROTEIN, MOUSE; PLCD1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM MOBILIZATION; CAVEOLA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; FEMALE; HYDROLYSIS; HYPERTENSION; ISOTOPE LABELING; LIPID RAFT; MESENTERY BLOOD FLOW; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; IN VITRO STUDY; MESENTERIC ARTERY; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CALCIUM; CAVEOLAE; CELLS, CULTURED; ENDOTHELIN-1; ESTRENES; FEMALE; HYDROLYSIS; IMMUNOBLOTTING; MESENTERIC ARTERIES; MICE; MYOGRAPHY; NOREPINEPHRINE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C DELTA; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VASOCONSTRICTION;

EID: 52449132391     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01396.2007     Document Type: Article

References (50)

1. 2+ ion concentrations. Biochem J 327: 545-552, 1997.
2. Altmann C, Steenpass V, Czyborra P, Hein P, Michel MC. Comparison of signaling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br J Pharmacol 138: 261-271, 2003.
3. Ananthanarayanan B, Das S, Rhee SG, Murray D, Cho W. Membrane targeting of C2 domains of phospholipase C-delta isoforms. J Biol Chem 277: 3568-3575, 2002.
4. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 28: 555-562, 2003.
5. Banno Y, Okano Y, Nozawa Y. Thrombin-mediated phosphoinositide hydrolysis in Chinese hamster ovary cells overexpressing phospholipase C-delta 1. J Biol Chem 269: 15846-15852, 1994.
6. Batty IH, Carter AN, Challiss RAJ, Hawthorne JN. Receptor-linked phosphoinositide metabolism. In: Neurochemistry, edited by Turner AJ and Bachelard HS. Oxford, UK: Oxford University Press, 1997, p. 229-268.
7. Bergdahl A, Sward K. Caveolae-associated signalling in smooth muscle. Can J Physiol Pharmacol 82: 289-299, 2004.
8. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255: 756-768, 1990.
9. Brenner R, Perez GJ, Bonev AD, Eckman DR, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW. Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature 407: 870-876, 2000.
10. Chen S, Lin F, Iismaa S, Lee KN, Birckbichler PJ, Graham RM. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem 271: 32385-32391, 1996.
11. Cho W, Stahelin RV. Membrane binding and subcellular targeting of C2 domains. Biochim Biophys Acta 1761: 838-849, 2006.
12. Clarke CJ, Ohanian V, Ohanian J. Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinase. Am J Physiol Heart Circ Physiol 292: H2248-H2256, 2007.
13. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100: 121-129, 2007.
14. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
15. Feldstein C, Romero C. Role of endothelins in hypertension. Am J Ther 14: 147-153, 2007.
16. Feng JF, Rhee SG, Im MJ. Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem 271: 16451-16454, 1996.
17. Griendling KK, Rittenhouse SE, Brock TA, Eckstein LS, Gimbrone LM, Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II stimulated vascular smooth muscle cells. J Biol Chem 261: 5901-5906, 1986.
18. Guo Y, Rebecchi M, Scarlata S. Phospholipase Cbeta2 binds to and inhibits phospholipase Cdelta1. J Biol Chem 280: 1438-1447, 2005.
19. Homma Y, Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J 14: 286-291, 1995.
20. Im MJ, Russell MA, Feng JF. Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal 9: 477-482, 1997.
21. Irino Y, Cho H, Nakamura Y, Nakahara M, Furutani M, Suh PG, Takenawa T, Fukami K. Phospholipase C delta-type consists of three isozymes: bovine PLCdelta2 is a homologue of human/mouse PLCdelta4. Biochem Biophys Res Commun 320: 537-543, 2004.
22. Je HD, Gallant C, Leavis PC, Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H91-H98, 2004.
23. Kato H, Fukami K, Shibasaki F, Homma Y, Takenawa T. Enhancement of phospholipase C δ1 activity in the aortas of spontaneously hypertensive rats. J Biol Chem 267: 6483-6487, 1992.
24. Katsuya T, Higaki J, Miki T, Kohara K, Yagisawa H, Tanase H, Mikami H, Serikawa T, Nojima H, Ogihara T. Hypotensive effect associated with a phospholipase C-delta 1 gene mutation in the spontaneously hypertensive rat. Biochem Biophys Res Commun 187: 1359-1366, 1992.
25. Keller M, Lidington D, Vogel L, Peter BF, Sohn HY, Pagano PJ, Pitson S, Spiegel S, Pohl U, Bolz SS. Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J 20: 702-704, 2006.
26. Kim YH, Park TJ, Lee YH, Baek KJ, Suh PG, Ryu SH, Kim KT. Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J Biol Chem 274: 26127-26134, 1999.
27. Kosugi T, Osanai T, Kamada T, Nakano T, Okumura K. Phospholipase C activity is enhanced in skin fibroblasts obtained from patients with essential hypertension. J Hypertens 21: 583-590, 2003.
28. LaBelle EF, Wilson K, Polyak E. Subcellular localization of phospholipase C isoforms in vascular smooth muscle. Biochim Biophys Acta 1583: 273-278, 2002.
29. Li XA, Everson WV, Smart EJ. Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med 15: 92-96, 2005.
30. Maron MB, Folkesson HG, Stader SM, Walro JM. PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization. Am J Physiol Lung Cell Mol Physiol 289: L349-L354, 2005.
31. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem 269: 10935-10939, 1994.
32. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19: 1173-1176, 2001.
33. i/o-coupled receptor agonists. Am J Physiol Cell Physiol 287: C1679-C1687, 2004.
34. Nakamura Y, Fukami K, Yu H, Takenaka K, Kataoka Y, Shirakata Y, Nishikawa S, Hashimoto K, Yoshida N, Takenawa T. Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J 22: 2981-2991, 2003.
35. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264: 1593-1596, 1994.
36. Ohanian J, Ohanian V, Shaw L, Bruce C, Heagerty AM. Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries. Br J Pharmacol 120: 653-661, 1997.
37. Ohanian J, Ollerenshaw J, Collins P, Heagerty AM. Agonist-induced production of 1,2-diacylglycerol and phosphatidic acid in intact resistance arteries- evidence that accumulation of diacylglycerol is not a prerequisite for contraction. J Biol Chem 265: 8921-8928, 1990.
38. Ollerenshaw J, Heagerty AM, Swales JD. Noradrenaline stimulation of the phosphoinositide system: evidence for a novel hydrophobic inositol-containing compound in resistance arterioles. Br J Pharmacol 94: 363-370, 1988.
39. Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80: 1291-1335, 2000.
40. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70: 281-312, 2001.
41. Shaw L, Sweeney MA, O'Neill SC, Jones CJ, Austin C, Taggart MJ. Caveolae and sarcoplasmic reticular coupling in smooth muscle cells of pressurised arteries: the relevance for Ca(2+) oscillations and tone. Cardiovasc Res 69: 825-835, 2006.
42. Sidhu RS, Clough RR, Bhullar RP. Regulation of phospholipase C-delta1 through direct interactions with the small GTPase Ral and calmodulin. J Biol Chem 280: 21933-21941, 2005.
43. 2+ sensitivity of smooth muscle and non-muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
44. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G. The alpha1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109: 765-775, 2002.
45. Villalobos-Molina R, Lopez-Guerrero JJ, Ibarra M. Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br J Pharmacol 126: 1534-1536, 1999.
46. Wu D, Katz A, Lee CH, Simon MI. Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J Biol Chem 267: 25798-25802, 1992.
47. Xu KM, Tang F, Han C. Alterations of mRNA levels of alpha 1-adrenoceptor subtypes with maturation and ageing in different rat blood vessels. Clin Exp Pharmacol Physiol 24: 415-417, 1997.
48. Yagisawa H, Sakuma K, Paterson HF, Cheung R, Allen V, Hirata H, Watanabe Y, Hirata M, Williams RL, Katan M. Replacements of single basic amino acids in the pleckstrin homology domain of phospholipase C-delta1 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane. J Biol Chem 273: 417-424, 1998.
49. Yamaga M, Sekimata M, Fujii M, Kawai K, Kamata H, Hirata H, Homma Y, Yagisawa H. A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells 9: 25-37, 2004.
50. Yin HL, Janmey PA. Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol 65: 761-789, 2003.